SNS-102

N/A

Report date: 2022/03/16 17:41:29

Base Information

Drug NameSNS-102
Drug Alias NameAnti-VSIG4 monoclonal antibodies(Sensei Biotherapeutics)SNS-VSIG4SNS-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-V-set and immunoglobulin domain-containing protein 4
TargetsV-set and immunoglobulin domain-containing protein 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSensei Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSensei Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A